Literature DB >> 17064696

Sphingosine kinase-1 is cleaved by cathepsin B in vitro: identification of the initial cleavage sites for the protease.

Tarek A Taha1, Mazen El-Alwani, Yusuf A Hannun, Lina M Obeid.   

Abstract

Previous work has identified sphingosine kinase-1 (SK1) as a substrate for the cysteine protease cathepsin B in vitro. In this study, the mechanism of SK1 cleavage by cathepsin B was investigated. We identified two initial cleavage sites for the protease, the first at histidine 122 and the second at arginine 199. Mutation analysis showed that replacement of histidine 122 with a tyrosine maintained the activity of SK1 while significantly reducing cleavage by cathepsin B at the initial cleavage site. The efficacy of cleavage of SK1 at arginine 199, however, was not affected. These studies demonstrate that SK1 is cleaved by cathepsin B in a sequential manner after basic amino acids, and that the initial cleavages at the two identified sites occur independently of each other.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064696      PMCID: PMC1732625          DOI: 10.1016/j.febslet.2006.09.070

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

Review 1.  Lysosomal cysteine proteases: facts and opportunities.

Authors:  V Turk; B Turk; D Turk
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 2.  Noncaspase proteases in apoptosis.

Authors:  D E Johnson
Journal:  Leukemia       Date:  2000-09       Impact factor: 11.528

3.  Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B.

Authors:  Meng Guo; Patricia A Mathieu; Bruce Linebaugh; Bonnie F Sloane; John J Reiners
Journal:  J Biol Chem       Date:  2002-01-28       Impact factor: 5.157

4.  In vivo expression of an alternatively spliced human tumor message that encodes a truncated form of cathepsin B. Subcellular distribution of the truncated enzyme in COS cells.

Authors:  S Mehtani; Q Gong; J Panella; S Subbiah; D M Peffley; A Frankfater
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

5.  Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis.

Authors:  A A Sinha; M P Jamuar; M J Wilson; J Rozhin; B F Sloane
Journal:  Prostate       Date:  2001-11-01       Impact factor: 4.104

6.  Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria.

Authors:  O Cuvillier; T Levade
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

Review 7.  Multiple cell death pathways as regulators of tumour initiation and progression.

Authors:  Marja Jäättelä
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

Review 8.  Pericellular cathepsin B and malignant progression.

Authors:  Stefanie Roshy; Bonnie F Sloane; Kamiar Moin
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

9.  Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B.

Authors:  Jennifer E Koblinski; Julie Dosescu; Mansoureh Sameni; Kamiar Moin; Katherine Clark; Bonnie F Sloane
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

10.  Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins.

Authors:  Tina Cirman; Kristina Oresić; Gabriela Droga Mazovec; Vito Turk; John C Reed; Richard M Myers; Guy S Salvesen; Boris Turk
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

View more
  15 in total

Review 1.  Regulation and functional roles of sphingosine kinases.

Authors:  Regina Alemany; Chris J van Koppen; Kerstin Danneberg; Michael Ter Braak; Dagmar Meyer Zu Heringdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-23       Impact factor: 3.000

Review 2.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 3.  Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.

Authors:  Christopher R Gault; Lina M Obeid
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-08       Impact factor: 8.250

4.  Sphingosine kinase 1 isoform-specific interactions in breast cancer.

Authors:  Daniel Yagoub; Marc R Wilkins; Angelina J Lay; Dominik C Kaczorowski; Diana Hatoum; Sarah Bajan; Gyorgy Hutvagner; Jack H Lai; Wengen Wu; Rosetta Martiniello-Wilks; Pu Xia; Eileen M McGowan
Journal:  Mol Endocrinol       Date:  2014-09-12

5.  Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.

Authors:  Bill X Wu; Youssef H Zeidan; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2009-04-02

6.  Cathepsin B mediates cleavage of herpes simplex virus type 1 origin binding protein (OBP) to yield OBPC-1, and cleavage is dependent upon viral DNA replication.

Authors:  Malen A Link; Laurie A Silva; Priscilla A Schaffer
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

Review 7.  Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment.

Authors:  Sue Chin Lee; Kuan-Hung Lin; Andrea Balogh; Derek D Norman; Mitul Bavaria; Bryan Kuo; Junming Yue; Louisa Balázs; Zoltán Benyó; Gábor Tigyi
Journal:  Cell Signal       Date:  2020-11-28       Impact factor: 4.315

8.  Site-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants.

Authors:  Verena K Hehle; Matthew J Paul; Victoria A Roberts; Craig J van Dolleweerd; Julian K-C Ma
Journal:  FASEB J       Date:  2015-12-28       Impact factor: 5.191

9.  Inhibition of ceramide metabolism sensitizes human leukemia cells to inhibition of BCL2-like proteins.

Authors:  Lavona Casson; Lauren Howell; Lesley A Mathews; Marc Ferrer; Noel Southall; Rajarshi Guha; Jonathan M Keller; Craig Thomas; Leah J Siskind; Levi J Beverly
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

10.  c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer.

Authors:  Leann S Fiore; Sourik S Ganguly; James Sledziona; Michael L Cibull; Chi Wang; Dana L Richards; Janna M Neltner; Carol Beach; Joseph R McCorkle; David M Kaetzel; Rina Plattner
Journal:  Oncogene       Date:  2013-10-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.